In vitro activity of Plazomicin against Enterobacteriaceae isolates carrying genes encoding aminoglycoside-modifying

Mariana Castanheira1, Andrew P Davis1, Alisa W Serio2

  • 1JMI Laboratories, North Liberty, IA 52317.

Insights

Aminoglycoside-modifying enzyme (AME) genes are common in resistant Gram-negative bacteria. Plazomicin effectively inhibits AME-carrying isolates, offering a vital option for difficult-to-treat infections.

Area of Science:

  • Microbiology
  • Antimicrobial Resistance
  • Infectious Diseases

Background:

  • Aminoglycoside resistance is a growing threat in Gram-negative bacterial infections.
  • Aminoglycoside-modifying enzymes (AMEs) are a primary mechanism of resistance.
  • Limited treatment options exist for infections caused by aminoglycoside-resistant bacteria.

Purpose of the Study:

  • To screen aminoglycoside-nonsusceptible Gram-negative isolates for AME and 16S rRNA methyltransferase genes.
  • To evaluate the in vitro activity of plazomicin against these resistant isolates.
  • To compare plazomicin's efficacy with other aminoglycosides.

Main Methods:

  • Screening of 480 Gram-negative isolates from US hospitals (2014-2015) for resistance genes.
  • Detection of 16S rRNA methyltransferase and AME genes using molecular methods.
  • Antimicrobial susceptibility testing, including minimum inhibitory concentrations (MICs) for plazomicin and comparators.

Main Results:

  • AME genes were found in 89.7% of isolates; common genes included aac(3)-IIa and aac(6')-Ib.
  • Only 5 isolates carried 16S rRNA methyltransferases.
  • Plazomicin demonstrated potent activity (MIC50/90, 0.5/1 μg/ml), inhibiting 99.3% of AME-carrying isolates, significantly outperforming amikacin, gentamicin, and tobramycin.

Conclusions:

  • AME genes are prevalent in aminoglycoside-nonsusceptible Gram-negative bacteria.
  • Plazomicin exhibits significant in vitro activity against a broad range of AME-producing Gram-negative pathogens.
  • Plazomicin represents a valuable therapeutic option for complicated urinary tract infections with limited treatment choices.

Related Concept Videos

Estimation of k and VD of Aminoglycosides01:20

Estimation of k and VD of Aminoglycosides

Aminoglycosides are a class of antibiotics used to treat various bacterial infections. Clinicians must determine the elimination rate constant (k) and volume of distribution (VD) to optimize therapeutic efficacy and minimize toxicity. The k value represents the rate at which the drug is removed from the body, and the VD reflects the degree to which the drug distributes into body tissues. Accurately estimating these parameters allows healthcare professionals to tailor drug dosing to individual...
240
Enzymes and Activation Energy01:13

Enzymes and Activation Energy

The activation energy (or free energy of activation), abbreviated as Ea, is the small amount of energy input necessary for all chemical reactions to occur. During chemical reactions, certain chemical bonds break, and new ones form. For example, when a glucose molecule breaks down, bonds between the molecule's carbon atoms break. Since these are energy-storing bonds, they release energy when broken. However, the molecule must be somewhat contorted to get into a state that allows the bonds to...
23.6K
Enzymes02:34

Enzymes

Inside living organisms, enzymes act as catalysts for many biochemical reactions involved in cellular metabolism. The role of enzymes is to reduce the activation energies of biochemical reactions by forming complexes with its substrates. The lowering of activation energies favor an increase in the rates of biochemical reactions.
Enzyme deficiencies can often translate into life-threatening diseases. For example, a genetic abnormality resulting in the deficiency of the enzyme G6PD...
94.7K
tRNA Activation02:26

tRNA Activation

Aminoacyl-tRNA synthetases are present in both eukaryotes and bacteria. Though eukaryotes have 20 different aminoacyl-tRNA synthetases to couple to 20 amino acids, many bacteria do not have genes for all of these aminoacyl-tRNA synthetases. Despite this, they still use all 20 amino acids to synthesize their proteins. For instance, some bacteria do not have the gene encoding the enzyme that couples glutamine with its partner tRNA. In these organisms, one enzyme adds glutamic acid to all of the...
22.9K
Common Ion Effect03:24

Common Ion Effect

Compared with pure water, the solubility of an ionic compound is less in aqueous solutions containing a common ion (one also produced by dissolution of the ionic compound). This is an example of a phenomenon known as the common ion effect, which is a consequence of the law of mass action that may be explained using Le Châtelier’s principle. Consider the dissolution of silver iodide:
46.6K
Genome Size and the Evolution of New Genes03:21

Genome Size and the Evolution of New Genes

While every living organism has a genome of some kind (be it RNA, or DNA), there is considerable variation in the sizes of these blueprints. One major factor that impacts genome size is whether the organism is prokaryotic or eukaryotic. In prokaryotes, the genome contains little to no non-coding sequence, such that genes are tightly clustered in groups or operons sequentially along the chromosome. Conversely, the genes in eukaryotes are punctuated by long stretches of non-coding sequence.
9.1K